
Leadership Team
Petra Zeller
Chief Operating Officer

Petra joined AMAL Therapeutics in 2023 as Chief Operating Officer.
Petra has more than 20 years of experience in leading the operational strategy and clinical operations for global biotech companies, including cross-functional project management, execution of clinical studies of all clinical phases, managing and overseeing outsourcing to CROs and different functional vendors.
Petra holds a degree in Pharmacy from the University of Munich, Germany.
